{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:36:07Z","timestamp":1776684967521,"version":"3.51.2"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T00:00:00Z","timestamp":1299196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u00a0<\/jats:bold> Psychiatric disorders have been shown to be associated with impaired immune response, including decreased cellular immunity to varicella\u2010zoster virus. However, the risk of herpes zoster (HZ) in psychiatric patients is, to date, unknown.<\/jats:p><jats:p><jats:bold>Objective\u00a0<\/jats:bold> The aim of this study was to determine the risk of herpes zoster (HZ) in psychiatric patients compared with the general population.<\/jats:p><jats:p><jats:bold>Methods\u00a0<\/jats:bold> We used data from the Taiwan Longitudinal Health Insurance Database from 2004 to 2006. Our study cohort consisted of patients aged 18\u2003years and older diagnosed with psychiatric disorders in 2004 (<jats:italic>N<\/jats:italic>\u2003=\u200342\u2003340). The comparison cohort (<jats:italic>N<\/jats:italic>\u2003=\u2003169\u2003360) consisted of four age\u2010 and gender\u2010matched controls randomly selected for every patient in the study cohort. All subjects were followed from the date of cohort entry until they developed HZ or the end of 2006, whichever was earliest. Stratified Cox proportional hazard regressions were performed to compute the 2\u2010year HZ\u2010free survival rates.<\/jats:p><jats:p><jats:bold>Results\u00a0<\/jats:bold> After adjusting for potential confounders, we found patients with psychiatric disorders were more likely to have an episode of HZ than the control population [adjusted hazard ratio (HR), 1.29; 95% confidence interval (CI), 1.18\u20131.38]. When stratified by age and psychiatric diagnostic categories, in patients aged \u226460\u2003years, the adjusted HRs for HZ were 1.34 (<jats:italic>P<\/jats:italic>\u2003=\u20030.026) for patients with affective psychoses, 1.42 (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) for those with neurotic illness or personality disorders and 1.53 (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) for patients with other mental disorders. However, in patients aged &gt;60\u2003years, only neurotic illness or personality disorders were significantly associated with an increased risk of HZ (adjusted HR, 1.26; <jats:italic>P<\/jats:italic>\u2003=\u20030.003).<\/jats:p><jats:p><jats:bold>Conclusions\u00a0<\/jats:bold> Our analysis suggests that patients with psychiatric disorders are at increased risk of HZ, especially those aged \u226460\u2003years. Further study is required to elucidate the nature of this association.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2010.03811.x","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T10:19:37Z","timestamp":1280312377000},"page":"447-453","source":"Crossref","is-referenced-by-count":18,"title":["Risk of herpes zoster among patients with psychiatric diseases: a population\u2010based study"],"prefix":"10.1111","volume":"25","author":[{"given":"Y\u2010W","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u2010H","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u2010W","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,4]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1885","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Straus SE","year":"2008"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/19.5.471"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00857-0"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/003591576505800106"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/379048"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000243079"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199307000-00004"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1990.tb01497.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810260079012"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.113.3.472"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/514272"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-007-9238-7"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199505000-00008"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1998.tb02751.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/605611"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2006.00563.x"},{"key":"e_1_2_7_18_2","first-page":"A14","article-title":"The vital link between chronic disease and depressive disorders","volume":"2","author":"Chapman DP","year":"2005","journal-title":"Prev Chronic Dis"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2006.57.8.1140"},{"key":"e_1_2_7_20_2","first-page":"571","article-title":"Postherpetic neuralgia","volume":"25","author":"Hope\u2010Simpson RE","year":"1975","journal-title":"J R Coll Gen Pract"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440320117011"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000123261.00004.29"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607043350107"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.101.1.200"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.1995.tb02723.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1977.tb02424.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.07.006"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(99)00076-8"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/514254"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90343-8"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-7-1"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2010.03811.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2010.03811.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:48:53Z","timestamp":1697399333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2010.03811.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1468-3083.2010.03811.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03811.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,4]]}}}